Proteros and University of Cincinnati, Drug Discovery Center establish collaboration to offer high-throughput screening services
Proteros now offers a comprehensive range of services for drug discovery from its own integrated lead discovery platform that includes a 30,000 member proprietary compound and fragment library, innovative kinetic and thermodynamic HTS assay technologies and structure guided medicinal chemistry to a traditional high-throughput screening approach. The structure guided approach is particularly suited to kinase targets, epigenetics targets and protein- protein interactions.
Cony D’Cruz Chief Business Officer and President Proteros US, Inc. stated, “We are very pleased to be able to offer this broad collection of discovery services to meet the diverse target and project needs of our clients. Proteros continues to enhance its service offering to enable our clients to improve the quality and productivity of their discovery efforts.”
Most read news
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.